Clinical trials: Multiparametric MRI
Prostate Carcinoma, Localized Prostate Adenocarcinoma
Early Magnetic Resonance Imaging Response of the Dominant Intraprostatic Lesion After Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer and Correlation With Prostate Specific Antigen Response
The aim of this phase II study is to determine the early multiparametric magnetic resonance imaging response of the dominant intraprostatic lesion and correlate these findings with prostate specific antigen response in patients…
- Conditions
- Prostate Carcinoma, Localized Prostate Adenocarcinoma, Stereotactic Body Radiotherapy, Stereotactic Radiotherapy
- Trial name
- PRODART (NCT06822491)
- Where
- Switzerland
- Volunteers
- 28 people
- Sponsor
- University of Zurich
Multiparametric MRI
Reproducibility of Multiparametric Renal Magnetic Resonance Imaging on 1.5T MRI Scanners
This is an interventional, multicenter, prospective study involving healthy volunteers, to primarily assess the reproducibility of multiparametric renal MRI on 1.5T scanners.
- Trial name
- NCT06884410
- Testing
- MRI
- Where
- 4 sites in Denmark, Germany and 2 more
- Volunteers
- 48 people, healthy volunteers welcome
- Sponsor
- Mario Negri Institute for Pharmacological Research
Multiparametric MRI, Lesion PI-RADS 3
The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targeted Biopsy. (PANDORA)
Prostate Specific Membrane Antigen (PSMA) positron emission tomography/computed tomography (PET/CT), an imaging modality focusing on a protein overexpressed by prostate cancer cells, has revolutionised the staging of both newly…
- Trial name
- PANDORA (NCT06867588)
- Testing
- PSMA PET
- Where
- Belgium
- Volunteers
- 68 people
- Sponsor
- Jules Bordet Institute
Breast Cancer, Chemotherapy Effect
The Prediction Model of NAC Response for Breast Cancer Based on The Parametric Dynamics Features.
The main purpose of this study is to develop a computer-aided prediction model for NAC treatment response. Based on the heterogeneity of internal parametric tumor composition commonly observed, this study will utilize the…
- Conditions
- Breast Cancer, Chemotherapy Effect, Diffusion Weighted MRI, PET Imaging
- Trial name
- NCT06370234
- Testing
- Whole body 18F-FDG Positron Emission Tomography
- Volunteers
- 60 people
- Sponsor
- National Taiwan University Hospital
Prostate Cancer, Multiparametric MRI
Deep Learning Super Resolution Reconstruction for Fast and Motion Robust T2-weighted Prostate MRI
The aim of this study was therefore to investigate a new unrolled DL super resolution reconstruction of an initially low-resolution Cartesian T2 turbo spin echo sequence (T2 TSE) and compare it qualitatively and quantitatively to…
- Trial name
- NCT05820113
- Testing
- Deep learning based reconstruction of T2-TSE sequence
- Where
- Germany
- Volunteers
- 109 people
- Sponsor
- University Hospital, Bonn
Head and Neck Cancer, Multiparametric MRI
Use of Multiparametric MRI in the Management of Head and Neck Cancer: a Retrospective Analysis
The investigators aim to identify specific MRI parameters that could improve diagnostic accuracy of metastatic cervical lymph nodes in patients with a squamous cell carcinoma in the head and neck region.
- Conditions
- Head and Neck Cancer, Multiparametric MRI, Cervical Lymph Node
- Trial name
- NCT03991533
- Testing
- multiparametric MRI
- Volunteers
- 30 people
- Sponsor
- AZ Sint-Jan AV
Head and Neck Cancer, Multiparametric MRI
Use of Multiparametric MRI in the Management of Head and Neck Cancer: a Prospective Analysis
The investigators aim to validate specific MRI parameters that could improve diagnostic accuracy of metastatic cervical lymph nodes in patients with a squamous cell carcinoma in the head and neck region.
- Conditions
- Head and Neck Cancer, Multiparametric MRI, Cervical Lymph Node, Bone Invasion
- Trial name
- NCT03993665
- Where
- Belgium
- Volunteers
- 70 people
- Sponsor
- AZ Sint-Jan AV
Radical Cystectomy, Muscle-Invasive Bladder Carcinoma
Clinical Utility of VI-RADS in Diagnosis of MIBC
Bladder Cancer (BCa) is the 9th most common cancer worldwide. In general, BCa is presented as a non-muscle invasive bladder cancer (NMIBC) in 70% of patients and treated with transurethral resection of bladder tumor (TUR-BT).
- Conditions
- Radical Cystectomy, Muscle-Invasive Bladder Carcinoma, Multiparametric MRI, Vesical Imaging Report and Data System
- Trial name
- NCT05097404
- Where
- South Korea
- Volunteers
- 73 people
- Sponsor
- Samsung Medical Center
Prostate Cancer, Prostate Adenocarcinoma
MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate Ca
Phase II non-inferiority randomized trial of annual systematic biopsies versus mpMRI and targeted biopsies for men with low risk prostate cancer on active surveillance with any volume Gleason's Score 6, but no prior MRI imaging…
- Conditions
- Prostate Cancer, Prostate Adenocarcinoma, Multiparametric MRI, Gleason's Score 6
- Trial name
- NCT02564549
- Testing
- TRUS-guided biopsy, mpMRI with targeted biopsy
- Where
- United States
- Volunteers
- 28 people
- Sponsor
- Virginia Commonwealth University